NASDAQ:GUTS • US35168W1036
ChartMill assigns a Buy % Consensus number of 84% to GUTS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-30 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-28 | Ladenburg Thalmann | Initiate | Buy |
| 2025-08-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-15 | Canaccord Genuity | Initiate | Buy |
| 2025-02-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-02-28 | Evercore ISI Group | Initiate | Outperform |
| 2024-02-27 | Morgan Stanley | Initiate | Overweight |
11 analysts have analysed GUTS and the average price target is 5.34 USD. This implies a price increase of 978.02% is expected in the next year compared to the current price of 0.4958.
The consensus rating for FRACTYL HEALTH INC (GUTS) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.